{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:25:21Z","timestamp":1770431121871,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1989,6,1]],"date-time":"1989-06-01T00:00:00Z","timestamp":612662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[1989,6]]},"DOI":"10.1007\/bf00441517","type":"journal-article","created":{"date-parts":[[2004,11,12]],"date-time":"2004-11-12T02:37:47Z","timestamp":1100227067000},"page":"630-633","source":"Crossref","is-referenced-by-count":12,"title":["Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient"],"prefix":"10.1007","volume":"148","author":[{"given":"S.","family":"Doi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ha-Kawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Yabuuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1986.tb01491.x","volume":"92","author":"T Diamanstein","year":"1986","unstructured":"Diamanstein T, Osawa H (1986) The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies. Immunol Rev 92:5?27","journal-title":"Immunol Rev"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0171-2985(84)80077-7","volume":"167","author":"R Dopfer","year":"1984","unstructured":"Dopfer R, Niethammer D, Peter HH, Kniep EM, Monner DA, M\u00fchlradt PF (1984) In vivo effects of interleukin 2 on lymphocyte subpopulations in a patient with a combined immunodeficiency. Immunobiology 167:452?461","journal-title":"Immunobiology"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.4049\/jimmunol.130.6.2644","volume":"130","author":"N Flomenberg","year":"1983","unstructured":"Flomenberg N, Welte K, Mertelsmann R, Kernan N, Clobanu N, Venuta S, Feldman S, Kruger G, Kirkpatrick D, Dupont B, O'Reilly R (1983) Immunologic effects of interleukin 2 in primary immunodeficiency diseases. J Immunol 130:2644?2650","journal-title":"J Immunol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/294261a0","volume":"294","author":"R Ford","year":"1981","unstructured":"Ford R, Mehta S, Franzini D, Montagna R, Lachman L, Maizel A (1981) Soluble factor activation of human B lymphocytes. Nature 294:261?263","journal-title":"Nature"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/268154a0","volume":"268","author":"S Gillis","year":"1977","unstructured":"Gillis S, Smith KA (1977) Long term culture of tumor-specific cytotoxic T-cells. Nature 268:154?156","journal-title":"Nature"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0171-2985(86)80123-1","volume":"172","author":"M Gramatzti","year":"1986","unstructured":"Gramatzti M, N\u00fcsslein H, Burmester GR, R\u00f6dl W, Heyder N, Grote W, Monner DA, M\u00fchlradt PF, Kalden JR (1986) Intralymphatic interleukin 2 treatment in patients with acquired immunodeficiency syndrome: preliminary experience in three cases. Immunobiology 172:438?447","journal-title":"Immunobiology"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/291335a0","volume":"291","author":"CS Henny","year":"1981","unstructured":"Henny CS, Kuribayashi K, Kern DE, Gillis S (1981) Interleukin 2 augments natural killer cell activity. Nature 291:335?338","journal-title":"Nature"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/eji.1830151102","volume":"15","author":"Le thi Bich-Thuy","year":"1985","unstructured":"Le thi Bich-Thuy, Fauci AS (1985) Direct effect of interleukin 2 on the differentiation of human B cells which have not been pre-activated in vitro. Eur J Immunol 15:1075?1079","journal-title":"Eur J Immunol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/300267a0","volume":"300","author":"WJ Leonard","year":"1982","unstructured":"Leonard WJ, Depper JM, Uchiyama T, Smith KA, Waldmann TA, Green WC (1982) A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. Nature 300:267?269","journal-title":"Nature"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.134.1.157","volume":"134","author":"MT Lotze","year":"1985","unstructured":"Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA (1985) In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin-2. J Immunol 134:157?166","journal-title":"J Immunol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/312641a0","volume":"312","author":"MC Mingari","year":"1984","unstructured":"Mingari MC, Gerrosa F, Carra G, Accola RS, Moretta A, Zubler RH, Waldmann TA, Moretta L (1984) Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 312:641?643","journal-title":"Nature"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.181845","volume":"193","author":"DA Morgan","year":"1976","unstructured":"Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007?1008","journal-title":"Science"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4049\/jimmunol.134.2.959","volume":"134","author":"T Nakagawa","year":"1985","unstructured":"Nakagawa T, Hirano T, Nakagawa N, Yoshizaki K, Kishimoto T (1985) Effect of recombinant IL 2 and ?-IFN on proliferation and differentiation of human B cells. J Immunol 134:959?966","journal-title":"J Immunol"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.4049\/jimmunol.133.5.2442","volume":"133","author":"P Ralph","year":"1984","unstructured":"Ralph P, Jeong G, Welte K, Mertelsmann R, Rabin H, Henderson LE, Souza LM, Boone TC, Robb RJ (1984) Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL-2. J Immunol 133:2442?2445","journal-title":"J Immunol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4049\/jimmunol.127.3.1044","volume":"127","author":"O Saiki","year":"1981","unstructured":"Saiki O, Ralph P (1981) Induction of human immunoglobulin secretion. I. Synergic effect of B cell mitogen Cowan I plus T cell mitogen or factor. J Immunol 127:1044?1047","journal-title":"J Immunol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1073\/pnas.79.19.6008","volume":"79","author":"O Saiki","year":"1982","unstructured":"Saiki O, Ralph P, Cunningham-Rundles C, Good RA (1982) Three distinct stage of B-cell defects in common varied immuno-deficiency. Proc Natl Acad Sci USA 79:6008?6012","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.133.4.1920","volume":"133","author":"O Saiki","year":"1984","unstructured":"Saiki O, Shimizu M, Saeki Y, Kishimoto S, Kishimoto T (1984) Dissociation in the production of B cell-stimulation factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient. J Immunol 133:1920?1924","journal-title":"J Immunol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/eji.1830170925","volume":"17","author":"T Tanaka","year":"1987","unstructured":"Tanaka T, Saiki O, Doi S, Hatakeyama M, Doi T, Kohno T, Mori H Fujii M, Sugamura K, Negoro S, Taniguchi T, Kishimoto S (1987) Functional interleukin 2 receptors on B cells lacking Tac antigens. Eur J Immunol 17:1379?1381","journal-title":"Eur J Immunol"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/302305a0","volume":"302","author":"T Taniguchi","year":"1983","unstructured":"Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, Hamuro J (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302:305?310","journal-title":"Nature"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.78.4.2528","volume":"78","author":"DJ Volkman","year":"1982","unstructured":"Volkman DJ, Lane HC, Fauci AS (1982) Antigen-induced in vitro antibody production by humans: a model for B cell activation and immunoregulation. Proc Natl Acad Sci USA 78:2528?2531","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1084\/jem.160.5.1450","volume":"160","author":"TA Waldmann","year":"1984","unstructured":"Waldmann TA, Goldman CK, Robb RJ, Depper JM, Leonard WJ, Sharrow SO, Bongiovanni KF, Korsmeyer SJ, Green WC (1984) Expression of interleukin 2 receptors on activated human B cells. J Exp Med 160:1450?1466","journal-title":"J Exp Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1084\/jem.163.6.1607","volume":"163","author":"CM Weyard","year":"1986","unstructured":"Weyard CM, Goronzy J, Dallman MJ, Fathman CG (1986) Administration of recombinant interleukin 2 in vivo induces a polyclonal IgM response. J Exp Med 163:1607?1612","journal-title":"J Exp Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00441517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00441517\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00441517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T05:00:44Z","timestamp":1682830844000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00441517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["BF00441517"],"URL":"https:\/\/doi.org\/10.1007\/bf00441517","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}